ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

NCI Considering DRCCA Request to Fund More CCOPs for Better Distribution; Some Will Be Rereviewed

August 19, 1983

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

DCT Board To Consider RFA for Clinical R01 Grants At Next Meetings

January 21, 1994

In Brief: INTRA-NCI Scramble For Funds involves “Tricks, Machinations, Day To Day Battle”

July 16, 1976

Hypothyroidism Associated With Reduced Breast Cancer

April 25, 2003

Cancer Death Rate Declines, Clark Tells Science Writers

April 8, 1977